Sg3 Management, LLC Iveric Bio, Inc. Call Options Transaction History

Sg3 Management, LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2023 May 15, 2023	SELL	$18.67 - $24.56 $429,410 - $564,880	-23,000 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$9.4 - $18.59 $216,200 - $427,570	23,000 New	23,000 $412,000
Q3 2022 Nov 14, 2022	BUY	$9.4 - $18.59 $169,200 - $334,620	18,000 Added 360.0%	23,000 $413,000
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $1.16 Million - $2.41 Million	-127,500 Reduced 96.23%	5,000 $48,000
Q1 2022 May 16, 2022	BUY	$12.15 - $16.83 $1.49 Million - $2.06 Million	122,500 Added 1225.0%	132,500 $2.23 Million
Q4 2021 Feb 15, 2022	SELL	$13.83 - $18.78 $638,946 - $867,636	-46,200 Reduced 82.21%	10,000 $167,000
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $397,334 - $983,500	56,200 New	56,200 $913,000

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.